Ravi Reddy was elected ISBT president on Saturday at the 34th International Congress, which is under way in Dubai. “It is always satisfying to receive a vote of confidence from your professional ...

Dr Reddy's Laboratories on Saturday said the US health regulator has issued a Form 483 with two observations after inspecting its US-based facility. The US Food and Drug Administration completed a ...

Hero Ashwin Babu, known for entertaining audiences with unique concepts, is back with an exciting new film titled Vachhinavadu Gautam. This medico-thriller is directed by Mamindala M.R. Krishna and is ...

JM Financial has maintained Buy call on Dr. Reddy's Laboratories with a revised target price of Rs 1,418 (Earlier Rs 1,723). The current market price of Dr. Reddy's Laboratories Ltd. is Rs 1234.95 ...

"Dr. Reddy's is consolidating between ₹1,160-₹1,220 after a recent pullback. The stock has built a base near ₹1,170, acting as strong support. A breakout above ₹1,220 can trigger an up ...

Dr Reddy’s Laboratories is stepping up its focus on the domestic market with a multi-pronged strategy. The Hyderabad-based drug maker began to focus on bringing innovative drugs to the Indian ...

Pharmaceutical firm Dr Reddy's Laboratories announced its quarterly results for the March 2024 quarter on Friday. The company reported a 22% year-on-year rise in consolidated net profit ...

An indigenous system, developed by the DRDO, thwarted Pakistan's strikes. Dr G Satheesh Reddy, former chairperson of the Defence Research and Development Organisation (DRDO), praised the ...

Dr Reddy's Laboratories Ltd (NYSE:RDY) achieved record high revenue exceeding $3.8 billion and crossed the $1 billion threshold in EBITDA for the first time. The company reported a year-over-year ...

Dr Reddy's Laboratories shares are in focus on May 12 post-strong March quarter results, announced in the post-market hours on May 9. The pharma firm reported 22 percent year-on-year increase in ...